4//SEC Filing
PharMerica CORP 4
Accession 0001209191-16-098103
CIK 0001388195operating
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:35 PM ET
Size
9.3 KB
Accession
0001209191-16-098103
Insider Transaction Report
Form 4
WEISHAR GREGORY S
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock, $0.01 par value
2016-02-10$14.89/sh+166,664$2,481,627→ 826,834 total - Tax Payment
Common Stock, $0.01 par value
2016-02-10$27.75/sh−123,090$3,415,748→ 703,744 total - Exercise/Conversion
Stock Option (Right to Buy)
2016-02-10−166,664→ 0 totalExercise: $14.89Exp: 2016-03-03→ Common Stock, $.01 par value (166,664 underlying)
Holdings
- 1,500(indirect: By Son)
Common Stock, $0.01 par value
Footnotes (1)
- [F1]The options vested in the following amounts on the following dates: 41,666 options on 03/03/2010, 41,666 options on 03/03/2011, 41,666 options on 03/03/2012, and 41,666 options on 03/03/2013.
Documents
Issuer
PharMerica CORP
CIK 0001388195
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001388195
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:35 PM ET
- Size
- 9.3 KB